DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Ragni MV, Jankowitz RC, Jaworski K, Merricks EP, Kloos MT, Nichols TC.
Phase II prospective open-label trial of recombinant interleukin-11 in women with mild von Willebrand disease and refractory menorrhagia.
Thromb Haemost 2011;
106 (4) 641-645
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.